PEDIATRICS Vol. 60 No. 6 December 1977, pp. 845-849
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bierman, C. W.
Right arrow Articles by Dorsett, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bierman, C. W.
Right arrow Articles by Dorsett, C. S.

Acute and Chronic Theophylline Therapy in Exercise-Induced Bronchospasm

C. Warren Bierman M.D.1, Gail G. Shapiro M.D.1, William E. Pierson M.D.1, and Carol S. Dorsett B.A.1

1 Division of Allergy, Children's Orthopedic Hospital and Medical Center, and the Department of Pediatrics, University of Washington, School of Medicine, Seattle

This study examined the effectiveness of theophylline therapy in modifying exercise-induced bronchospasm (EIB) in children with perennial asthma and evaluated whether tolerance to theophylline developed with prolonged use.

Twenty-one children between 7 and 16 years of age were studied by a standardized treadmill exercise test carried out before administration of theophylline, 90 minutes after administration of theophylline, and again after three weeks of round-the-clock theophylline treatment. Changes in forced expiratory volume at one second, forced expiratory flow between 25% and 75% of vital capacity, and peak expiratory flow rate were measured before and after each exercise test.

Theophylline inhibited EIB in 20 of 21 subjects. There was considerable intersubject variation in the response to theophylline, however, ranging from complete inhibition in five subjects to no inhibition at all in one subject, even though theophylline controlled perennial asthma in all subjects, and all but one had theophylline levels between 10 and 22 µg/ml when tested. On repeated testing after three weeks of therapy, no tolerance developed to theophylline.

These findings suggest that EIB and perennial asthma may result from different causes and that theophylline's ability to control asthma will not predict its effect on EIB. Subjects who have severe EIB should be retested after theophylline pretreatment to evaluate the effectiveness of therapy.

Submitted on May 23, 1977
Accepted on September 27, 1977




This article has been cited by other articles:


Home page
 NEJMHome page
M. Weinberger and L. Hendeles
Theophylline in Asthma
N. Engl. J. Med., May 23, 1996; 334(21): 1380 - 1388.
[Full Text] [PDF]

Home page
 ANGIOLOGYHome page
R. Schmidt and S. Altschuler
The Usefulness of Theophylline in Nonasthmatic Airway Obstruction
Angiology, January 1, 1979; 30(11): 744 - 749.
[Abstract] [PDF]